Given the current findings, we designed a prospective cohort study to assess the association of survival rates and biomarkers, including PD-L1 expression and TIL density, in HNSCC patients indicated for definitive radiotherapy and/or radiochemotherapy. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.